Cargando…
Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro
Erchen decoction (ECD) and Linguizhugan decoction (LGZGD), both are Chinese herbal formula, have been used clinically for the treatment of nonalcoholic fatty liver disease (NAFLD). However, their therapeutic mechanisms are still unclear. Because insulin resistance (IR) is a key etiological factor in...
Autores principales: | Zhang, Huicun, Ta, Na, Chen, Pengmin, Wang, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467344/ https://www.ncbi.nlm.nih.gov/pubmed/28630632 http://dx.doi.org/10.1155/2017/1589871 |
Ejemplares similares
-
Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Cheng, Ya, et al.
Publicado: (2022) -
Retracted: Erchen Decoction Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Erchen decoction for hyperlipemia: Protocol for a systematic review and meta-analysis
por: Luo, Huan, et al.
Publicado: (2020) -
Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome
por: Zhang, Huicun, et al.
Publicado: (2022) -
Erchen decoction combined with Sanziyangqin decoction for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Deng, Lu, et al.
Publicado: (2020)